tradingkey.logo

tradingkey.logo
怜玢


Pharming Group NV

PHAR
りォッチリストに远加
12.600USD
-0.350-2.70%
終倀 11-13 16:00ET
891.80M時䟡総額
0.00盎近12ヶ月PER

Pharming Group NVに぀いお 䌁業名

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Pharming Group NV プロフィヌル


䌁業コヌドPHAR
䌚瀟名Pharming Group NV
䞊堎日Jul 02, 1998
最高経営責任者「CEO」Chouraqui (Fabrice)
埓業員数- -
蚌刞皮類Depository Receipt
決算期末- -
本瀟所圚地Darwinweg 24
郜垂LEIDEN
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Netherlands
郵䟿番号2333 CR
電話番号31715247400
りェブサむトhttps://www.pharming.com/
䌁業コヌドPHAR
䞊堎日Jul 02, 1998
最高経営責任者「CEO」Chouraqui (Fabrice)

Pharming Group NVの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Ruud van Outersterp
Mr. Ruud van Outersterp
Chief Legal and Compliance Officer, Company Secretary
Chief Legal and Compliance Officer, Company Secretary
--
--
Ms. Maryana Reurings-Tsiganko
Ms. Maryana Reurings-Tsiganko
Vice President - Strategy and Operations
Vice President - Strategy and Operations
--
--
Dr. Elaine Sullivan, Ph.D.
Dr. Elaine Sullivan, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Leverne Marsh
Ms. Leverne Marsh
Interim Co-Chief Executive Officer, Chief Commercial Officer
Interim Co-Chief Executive Officer, Chief Commercial Officer
--
--
Mr. Kenneth Lynard
Mr. Kenneth Lynard
Interim Co-Chief Executive Officer, Chief Financial Officer
Interim Co-Chief Executive Officer, Chief Financial Officer
--
--
Ms. Ines Bernal
Ms. Ines Bernal
Chief People Officer
Chief People Officer
--
--
Mr. Fabrice Chouraqui, Pharm.D.
Mr. Fabrice Chouraqui, Pharm.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Dr. Alexander Breidenbach, Ph.D.
Dr. Alexander Breidenbach, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
Dr. Richard Peters, M.D., Ph.D.
Dr. Richard Peters, M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Stephen (Steve) Toor
Mr. Stephen (Steve) Toor
Chief Commercial Officer
Chief Commercial Officer
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Ruud van Outersterp
Mr. Ruud van Outersterp
Chief Legal and Compliance Officer, Company Secretary
Chief Legal and Compliance Officer, Company Secretary
--
--
Ms. Maryana Reurings-Tsiganko
Ms. Maryana Reurings-Tsiganko
Vice President - Strategy and Operations
Vice President - Strategy and Operations
--
--
Dr. Elaine Sullivan, Ph.D.
Dr. Elaine Sullivan, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Leverne Marsh
Ms. Leverne Marsh
Interim Co-Chief Executive Officer, Chief Commercial Officer
Interim Co-Chief Executive Officer, Chief Commercial Officer
--
--
Mr. Kenneth Lynard
Mr. Kenneth Lynard
Interim Co-Chief Executive Officer, Chief Financial Officer
Interim Co-Chief Executive Officer, Chief Financial Officer
--
--
Ms. Ines Bernal
Ms. Ines Bernal
Chief People Officer
Chief People Officer
--
--

よくある質問

Pharming Group NVの䞊䜍5名の株䞻は誰ですか


Pharming Group NVの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Stephen (Steve) Toor

Pharming Group NVPHARの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Pharming Group NVの株匏を保有しおいる機関は22瀟あり、保有株匏の総垂堎䟡倀は玄135.73Kで、党䜓の0.19%を占めおいたす。2025Q4ず比范しお、機関の持ち株は61813.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。